Hypertrichosis in a newborn girl infant of a diabetic mother with congenital hypothyroidism is reported. Both neonatal hyperinsulism and increased testosterone levels were documented. The hypertrichosis resolved after 3 months' of thyroxine replacement treatment. The possible causal association between hypothyroidism, and hypertrichosis has not been previously reported in neonatal period. Thyroid function should be evaluated in all newborn babies with hypertrichosis or abnormal distribution of body hair.
Introduction
Congenital hypothyroidism (CH) is a relatively common congenital disorder occurring in about one of 3000 to one of 4000 live births. 1 As few signs or symptoms are present in the neonatal period, routine screening is the only means of detection.
2 Hypertrichosis, a rare condition, can be defined as an excessive growth of hair (terminal, vellus or lanugo) in areas of the body that are not predominantly androgen-dependent, and is independent of age, race or sex. 3 Hypothyroidism is usually associated with loss of hair, 4, 5 however, in older children has been associated with an increased amount of hair. [6] [7] [8] In addition, neonatal hairy pinna has been reported as pathognomonic sign in infants of diabetic mothers. 9 We wish to report a newborn girl infant of a diabetic mother with CH with significant hypertrichosis that resolved after 3 months' replacement treatment with thyroxine. This association has not been previously reported.
Case report A 3-day-old female infant with seizures was referred to our University Hospital. The baby was born by spontaneous vaginal delivery at 38 weeks of gestation. She was the seventh child of a 35-year-old mother and a healthy 40-year-old father. The parents were first-degree relatives. The family's first five children were healthy. The sixth child died on the third day after birth of unknown cause.
The seventh and eighth pregnancies ended with premature deliveries at 28 and 30th gestational weeks, respectively. During the current pregnancy, a 100-g 3-h oral glucose tolerance test was performed at 28th gestational week and gestational diabetes was diagnosed. Only dietary regulation was initiated and prenatal follow-up and management of the mother was not good.
At birth the infant weighed 3600 g (90th percentile), her height was 53 cm (>90th percentile) and head circumference was 35 cm (75-90th percentile). The baby was icteric and plump with puffy plethoric facies. Fine long hair was detected all over the body ( Figure 1 ). The child was noticed to be excessively hairy ( Figure 2) .
On admission to our pediatric emergency service, she was irritable with focal clonic seizures. Blood glucose, total calcium, magnesium and phosphorus concentrations were 27, 5.8, 0.7 and 4.2 mg/dl, respectively. After 5 ml/kg of 10% glucose as a bolus injection, a continued glucose infusion of 8 mg/kg/min was administered. Additional treatment included intravenous injection of 8 ml of a 10% solution of calcium gluconate at the rate of 1 ml/ min and intramuscular injection with 0.2 ml/kg of a 50% solution of MgSO 4 With these therapies, the serum glucose, calcium and magnesium concentrations became normal.
Laboratory findings include hemoglobin 21.2 g/dl, hematocrit 65%, and white blood cell count 22 000/mm 3 (60% neutrophil, 40% lymphocytes, 35% normoblast). The reticulocyte count was 1% and the platelet count was 162 000/mm 3 . The peripheral smear revealed normochromic-macrocytic erythrocyte morphology. Blood grouping of mother and baby were both A Rh ( þ ). Total bilirubin was 23.4 mg/dl with a direct component of 1.5 mg/dl. The result of direct Coombs test was negative. Serum electrolytes, blood urea nitrogen, creatinine, SGOT, SGPT, total protein, albumin and urinalysis were normal. Radiographic examination of the chest revealed mildly enlarged heart. Echocardiography showed a hypercontractile, thickened myocardium with septal hypertrophy. Double volume exchange transfusion was performed to reduce bilirubin to acceptable levels. Cranial ultrasonography was normal. Her karyotype was 46, XX. On the seventh day of life, total and free testosterone, 168.00 ng/dl (normal range: 20 to 64), and 3.81 pg/ml (normal range: 0.5 to 2.5), respectively. Sex hormone binding globulin concentration was 1.3 mg/dl (normal range: 1.5 to 6.3 mg/dl). The serum insulin level was 22.6 mU/ml (normal range: 2.0 to 13.0 mU/ml). And 17 a-hydroxyprogesterone, androstenedion, and dehydroepiandrosterone sulfate concentrations were all normal. Ultrasonographic examination of adrenal and ovaries was normal.
On follow-up the infant was noted to be lethargic with feeding difficulty, and knee X-ray noted absence of distal femoral epiphysis. Thyroid function tests were performed on the 10th day of life: free T3 0.76 pg/ml (normal range: 2.4 to 5.6 pg/ml), free T4 0.60 (normal range: 0.9 to 2.6 ng/dl) and TSH 55.7 (normal range: 3 to 18 mU/ml). Thyroid volume was measured 1.3 ml in a normal range.
Sodium-L-thyroxine (15 mg/kg) was given and the thyroid function tests became normal (free T3 2.37 pg/ml, free T4 1.79 ng/dl, TSH 0.58 mU/ml) within 30 days. Total testosterone, free testosterone, insulin, sex hormone binding globulin levels of infant were normalized around the end of the third month of life (38.00 ng/dl (normal range: 20 to 64 ng/dl), 1.71 pg/ml (normal range: 0.5 to 2.5 pg/ml), 3.1 mU/ml (normal range: 2.0 to 13.0 mU/ml), 4.8 mg/dl (normal range: 1.5 to 6.3 mg/dl), respectively). During 3 months her hypertrichosis resolved progressively.
Discussion
Hypertrichosis, defined as an increase in the nonandrogenmodulated hair on the body, may be congenital or acquired, localized or generalized. 10 Congenital hypertrichosis is a generic term for any excessive hair growth visible on a child at birth. The hair growth can be excessive for a wide variety of reasons and may involve the entire body with a mass of fine long hair, diffuse excess hair, or may be restricted to specific areas. Causes of congenital hypertrichosis vary. It is sometimes a secondary symptom of various syndromes with a genetic inheritance component.
11
A characteristic facial appearance in a child with hypertrichosis may lead to the recognition of one of a number of dysmorphic syndromes for example Brachmann-de Lange syndrome, CoffinSiris syndrome, Rubinstein-Taybi syndrome, Seckel's syndrome, cerebro-oculofacioskeletal syndrome, Gorlin's syndrome, Schinzel Giedion midface retraction syndrome or Barber Say syndrome. 12 It is unusual to find a cause of hypertrichosis or hirsutism and treatment is often unsatisfactory. 13 The causal association between hypothyroidism and hypertrichosis has not been reported in neonatal period, although congenitally hypothyroid infants often have a low hairline. Perloff reported four cases of what he called hirsutism in children, who responded to thyroxine replacement therapy. 6 Stern et al. 7 reported a 10-year-old girl with hypertrichosis associated with primary hypothyroidism that resolved by thyroxine therapy. Three children with untreated primary Figure 1 Fine long hair was detected all over the body. Figure 2 The child was noticed to be excessively hairy. hypothyroidism were reported by Nishi et al. 8 have pituitary hyperplasia, hypertrichosis and blunted growth hormone (GH) secretion. These abnormalities disappeared and improved after thyroid hormone therapy.
The pathophysiology of this relationship is unclear. Bilowus et al.
14 reported a newborn with female pseudohermaphroditism (profound masculinization of the external genitalia and preservation of the internal female genitalia). During pregnancy progressive hirsutism was noted in the mother, and polycystic ovaries were found at cesarean section. The serum testosterone level in the cord blood was elevated markedly (1232 ng/dl). After birth the serum testosterone levels of the mother and newborn decreased dramatically. They speculated that the polycystic ovaries were the source of the excessive androgen secretion that caused maternal and fetal masculinization during the pregnancy. There was no polycystic ovaries and elevated serum testosterone level in our infant's mother.
We followed up an infant of diabetic mother. On admission we detected hypertrichosis. In our baby, CH and additionally elevated insulin, free and total testosterone levels were detected. Stimulation of the growth of hair via adrenal androgens by thyroid stimulating hormone may be the pathophysiological mechanism in our patient. Shoupe et al. 15 reported that serum testosterone showed a positive correlation with insulin resistance, and sex hormone binding globulin showed a negative correlation. Our patient had three hormones, two of which increased (the serum levels of insulin and testosterone), and one of which decreased (the serum level sex hormone binding globulin). Hypertrichosis might also be related to free testosterone on account of hyperinsulinism in our patient. The fact that the hypertrichosis resolved after 3 months' replacement treatment with thyroxine supports the suggestion that the hair growth in this case was related to the interrelationship of thyroid function and androgen levels augmented by the hyperinsulinism.
In conclusion, we detected hypertrichosis concomitant with CH in an infant of diabetic mother. Given the fact that IDM neonates have hairy pinna, the generalized hypertrichosis may be part of the spectrum of the effect of the hyperinsulin state. However, as increased hair growth has been reported in older children with disturbances of thyroid function we suggest that full assessment of thyroid function be carried out in all newborn babies with hypertrichosis or abnormal distribution of body hair.
